TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity
Abstract Background TMEM52B is a novel gene broadly expressed in a variety of normal human tissues. However, the biological function of TMEM52B expression in cancer is largely unknown. Methods The effects of TMEM52B on tumor growth and metastasis were investigated in vitro and in vivo, and the under...
Main Authors: | Yunhee Lee, Dongjoon Ko, Junghwa Yoon, Younghoon Lee, Semi Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-021-01828-7 |
Similar Items
-
Prognostic significance of E-cadherin and N-cadherin expression in Gliomas
by: Myung-Giun Noh, et al.
Published: (2017-08-01) -
Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth
by: Katia Rea, et al.
Published: (2018-07-01) -
Validation of an Automated Quantitative Digital Pathology Approach for Scoring TMEM: A Prognostic Biomarker for Metastasis
by: David Entenberg, et al.
Published: (2020-03-01) -
Effects of systemic administration of HESA-A on the expression of cyclin D1 and EGFR and E-cadherin in the induced tongue dysplasia in rats
by: Shirin Fattahi, et al.
Published: (2017-12-01) -
A New Understanding of TMEM119 as a Marker of Microglia
by: Chunsheng Ruan, et al.
Published: (2022-06-01)